What is the Dongkook Life Science Co., Ltd. stock price forecast?

Dongkook Life Science Co., Ltd. is currently trading at ₩3,325. View real-time AI analysis on Alpha Lenz.

What is Dongkook Life Science Co., Ltd. insider trading activity?

View the latest insider trading data for Dongkook Life Science Co., Ltd. on Alpha Lenz.

What is Dongkook Life Science Co., Ltd.'s P/E ratio?

Dongkook Life Science Co., Ltd.'s P/E ratio is 38.0.

Dongkook Life Science Co., Ltd.

KRX · 303810

₩3,325-90(-2.64%)

Ask about Dongkook Life Science Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Dongkook Life Science Co., Ltd. trades at a P/E of 38.0 (premium valuation) with modest ROE of 2.6%.”

Ask for details →

Company Overview

Dongkook Life Science Co., Ltd. is a prominent entity in the pharmaceutical industry, focusing on the research, development, manufacture, and distribution of a wide array of healthcare products. Headquartered in South Korea, the company aims to improve health and well-being by offering innovative solutions in pharmaceuticals, medical devices, and health supplements. Notable for its comprehensive approach to healthcare, Dongkook Life Science has established itself in various segments, serving hospitals, clinics, pharmacies, and end consumers. Its operations encompass both domestic and international markets, reflecting its significant role in global health advancement. Strategic investments in new technologies and active research programs underscore its commitment to enhancing therapeutic options and accessibility.

CEO박재원

Websitehttps://www.dkls.co.kr

SectorHealthcare

IndustryMedical Instruments & Supplies

Company Statistics

FY 2024

Profile

₩106,347,265,500Market Cap

₩131,816,122,280Revenue

31.98MShares Out

0Employees

Margins

21.69%Gross

12.04%EBITDA

9.04%Operating

3.61%Pre-Tax

1.70%Net

Valuation

38.00P/E

0.81P/B

0.65EV/Sales

8.07EV/EBITDA

13.22P/FCF

Growth (CAGR)

8.69%Rev 3Yr

5.97%Rev 5Yr

20.58%Op Inc 3Yr

11.39%Op Inc 5Yr

-27.37%Net Inc 3Yr

-18.59%Net Inc 5Yr

Returns

1.21%ROA

2.58%ROE

4.39%ROIC

Financial Health

₩2,403,100,140Cash & Cash Equivalents

₩84,030,262,390Net Debt

82.14%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Dongkook Life Science Co., Ltd. trades at a P/E of 38.0 (premium valuation) with modest ROE of 2.6%.”

Ask for details →

Frequently Asked Questions

Dongkook Life Science Co., Ltd. (ticker: 303810) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). Market cap is $106.3B.

The current price is ₩3,325 with a P/E ratio of 38x and P/B of 0.81x.

ROE is 2.58% and operating margin is 9.04%. Annual revenue is $131.8B.